Board Member


Sean McCarthy

Chief Executive Officer, CytomX
Sean McCarthy has more than 18 years of experience in the biotechnology industry, including business development, venture capital, program management and research management. Prior to joining CytomX in January 2011, he was a transactional partner at Pappas Ventures responsible for investments in therapeutic, medical device and molecular diagnostic companies and new company formation. Prior to Pappas Ventures, Dr. McCarthy was the vice president of business development at SGX Pharmaceuticals Inc., where he spearheaded a wide range of strategic partnerships with major pharmaceutical companies, including a $515 million oncology alliance with Novartis, and led a strategic re-orientation that resulted in the successful initial public offering of the company in 2006. Prior to SGX, Dr. McCarthy was associate director of program management at Millennium Pharmaceuticals, where he managed therapeutic protein programs and a research team that invented novel genomic techniques for the identification of novel biologics. Dr. McCarthy is the author of 17 peer-reviewed scientific publications and a named inventor on six issued patents and 23 filed patent applications.
Dr. McCarthy received his B.Sc. in biochemistry and pharmacology at King’s College, University of London; his M.B.A. from the Rady School of Management at UC San Diego; and a D. Phil. in cancer biology from St. John’s College, University of Oxford.